Impact of Telemedicine on The Pharmaceutical Industry
Telehealth and Medicine Today · 2025
DOI: 10.30953/thmt.v10.589 ↗Abstract
This article analyzes the impact of telemedicine on the pharmaceutical industry from the perspective of the Pharmaceutical Products Industry Union of the State of São Paulo (Sindusfarma). A participatory research was conducted, with the monitoring of the work of the Digital Health Committee and analysis of the work and discussions that took place in the Marketing and Business Support, Regulatory, Legal Strategy and Access Committees, as well as interviews with industry representatives. The Global and Brazilian Digital Health Strategies and the pharmaceutical industry’s business model were evaluated to identify the impact of telemedicine on the business model. An opportunity map was presented for expanding the practice of telemedicine, with suggestions for actions for pharmaceutical companies and project considerations for Sindusfarma, aiming to contribute to the Digital Health Strategic Plan, to the innovation and modernization of the sector, and to increase patient access to information, prevention, diagnosis, and treatment.
EUVIMED